KRASG12C inhibition in colorectal cancer
Authors:
- 1 January 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Oncology
- Vol. 23 (1) , 10-11
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal CancerJCO Precision Oncology, 2021
- Sotorasib for Lung Cancers with KRAS p.G12C MutationNew England Journal of Medicine, 2021
- KRAS G12C Inhibition with Sotorasib in Advanced Solid TumorsNew England Journal of Medicine, 2020
- EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal CancerCancer Discovery, 2020
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal CancerNew England Journal of Medicine, 2019
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsNature, 2013